Microbiota in patients with cefuroxime resistance and anal fistula revealed by 16S ribosomal DNA

Table 1 Baseline of patients in cefuroxime-resistant and cefuroxime-sensitive groups, n (%)

Features	Cefur-NS (n = 9)	Cefur-S (n = 21)	Statistics	P value
Age	38.22 (12.91)	44.71 (12.98)	-1.26	0.227
Height	172.33 (6.30)	171.29 (6.25)	0.42	0.682
Weight	77.89 (13.05)	75.76 (17.78)	0.36	0.719
BMI	25.83 (24.07-29.39)	24.77 (22.68-25.47)	109.50	0.512
Sex	-	-	-	> 0.999
Female	1 (11.11)	2 (9.52)	-	-
Male	8 (88.89)	19 (90.48)	-	-

BMI: Body mass index; Cefur-S: Cefuroxime-sensitive; Cefur-NS: Cefuroxime-resistant.

Table 2 Comparison of outcomes before and after taking Clostridium butyricum tablets

Features	Before taking CBT	After taking CBT	Statistics	P value
Cefuroxime resistance (n)	9	2	-1.56	< 0.01
Defection frequency (times/day), mean ± SD	2.3 ± 1.2	1.7 ± 0.7	1.78	0.02
Stool consistency score, mean ± SD	19.3 ± 7.8	11.9 ± 8.1	-3.73	0.02

CBT: Clostridium butyricum tablets.